Aclaris Therapeutics, Inc.ACRSNASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank42
3Y CAGR-14.3%
5Y CAGR+17.8%
Year-over-Year Change
Total value of everything the company owns
3Y CAGR
-14.3%/yr
vs -2.0%/yr prior
5Y CAGR
+17.8%/yr
Recent deceleration
Acceleration
-12.3pp
Decelerating
Percentile
P42
Within normal range
vs 5Y Ago
2.3x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $160.46M | -27.2% |
| 2024 | $220.33M | +11.6% |
| 2023 | $197.41M | -22.5% |
| 2022 | $254.60M | +1.3% |
| 2021 | $251.21M | +254.9% |
| 2020 | $70.78M | -28.0% |
| 2019 | $98.30M | -64.3% |
| 2018 | $275.57M | +13.2% |
| 2017 | $243.51M | +38.3% |
| 2016 | $176.09M | - |